Novartis Pharma AG: Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio

Brimonidine tartrate/timolol maleate combination eyedrop is used to treat elevated eye pressure in patients with ocular hypertension1 Ocular hypertension affects over 5% of all adults2; the eye does

Related Keywords

United States ,Americans ,America ,American ,Isabella Zinck ,Chris Lewis ,Samir Shah ,Sloan Simpson ,Keren Haruvi ,Michelle Bauman ,Nicole Zinsli Somm ,Instagram ,Allergan Inc ,Linkedin ,Twitter ,Optometrists Network ,Sandoz Inc ,American Academy Of Ophthalmology ,Novartis ,Exchange Commission ,Facebook ,Sandoz Global Communications ,African Americans ,Severe Respiratory ,Cardiac Reactions ,Hypoglycemic Symptoms ,Full Prescribing Information ,Published July ,American Academy ,Published March ,Hypertension Diagnosis ,Prescription Ophthalmology Market ,Dharma ,Sandoz ,Aunches ,Generic ,Rimonidine ,Heartrate ,Imolol ,Aleate ,Eyedrop ,Patients ,Secular ,Hypertension ,Xpanding ,Reading ,Ophthalmic ,Portfolio ,